What's hot
View all perspectives
Peter Nash drpnash
1 year 4 months ago
Grappa difficult to treat PsA meeting - SLR, Patient & rheumo survey, definition eg - fail 1 csDMARD & 2 bDMARDs different MOA - names matter suggest ditch « difficult » for « refractory » @rheumnow #EULAR2024
Inhibition of B cell activating factor (BAFF) and B cell depletion are the two most evaluated strategies over the last 15 years in the field of SLE therapeutics, with licensing of belimumab and off-label use of rituximab. Despite this, some patients remain refractory to these effective therapies.
Dr. John Cush RheumNow
1 year 4 months ago
Australian studyshows knee OA pts unconsciously believe that activity may be dangerous to their condition, despite medical advice telling them otherwise. 69% of people with knee pain had stronger implicit (unconscious) beliefs that exercise was dangerous https://t.co/iytfpcGvD8 https://t.co/N183ffYfPP
Md Yuzaiful Md Yusof Yuz6Yusof
1 year 4 months ago
#EULAR2024 Opening Ceremony. @DanielAletaha highlighted values of @eular strategies that have been achieved:
Patient centredness ✔️
Innovation ✔️ - RheumaFacts, ENTRI, Exams
Inclusivity ✔️
To strive on 3 other values by next year under President-Elect @XBaraliakos @RheumNow https://t.co/wDR2vtv3I2
Mrinalini Dey DrMiniDey
1 year 4 months ago
📄 #EULARAdvocacy Chair @carmona_loreto discusses the @eular_org manifesto at the #EULAR2024 opening ceremony
🔗You can read the full manifesto and find out more here: https://t.co/6CZuSYpiLl
@RheumNow https://t.co/DYcU9I6rmR
Aurelie Najm AurelieRheumo
1 year 4 months ago
« We must work together to achieve a future where RMDs are no longer an invisible problem »
Wise words from @carmona_loreto during Opening Plenary session #EULAR2024
@RheumNow
TheDaoIndex KDAO2011
1 year 4 months ago
#AB1039 Spanish study 76 LN patients postrenal transplant: 77% females, HTN (68%), LN class IV (42%), mean age 55. Graft loss in 35.5% b/c of acute rjx (22%), chronic rjx (22%), acute w/chronic rjx (22%), graft thrombosis 14.8%, recur LN (11%) #EULAR24 @rheumnow https://t.co/d82i0Z7LUB
Dr. John Cush RheumNow
1 year 4 months ago
RheumNow’s expanded coverage of the #EULAR2024 Annual meeting is sponsored in part by Bristol Myers Squibb and UCB. All content is chosen by RheumNow & our Faculty
Dr. John Cush RheumNow
1 year 4 months ago
Final countdown to #EULAR2024 and we'll be there. We'll be sharing recaps, videos, and more. Are you ready for it?! https://t.co/BSrRATfxwt
Dr. John Cush RheumNow
1 year 4 months ago
Is Cannabis Safe? (6.7.2024)
Dr. Jack Cush reviews FDA approval, news and journal articles -- and it’s the week before EULAR 2024 in Vienna!!
https://t.co/tmCra58mYf https://t.co/KbMIDipvpI
Dr. John Cush RheumNow
1 year 4 months ago
Danish Registry study of 1.9 million chronic pain pts, shows chronic use of medicinal cannabis (5391) is assoc w/ a significant risk of new-onset arrhythmia {180d RR 2.07; 1-year RR 1.36). No significant association for acute coronary syndrome https://t.co/VT3X8lVWaD https://t.co/BMqVapFkuU
Dr. John Cush RheumNow
1 year 4 months ago
CATCH cohort study of 547 Early RA pts shows higher Tender > Swollen joint differences is assoc. w/ worse n patient-reported outcomes (PROs) in all domains (phys function, social , pain, sleep problems, fatigue, anxiety, depression) -- Isnt this FM ? https://t.co/4Bk8VGQNB6 https://t.co/K7kO5q990v
Dr. John Cush RheumNow
1 year 4 months ago
Cohort study of 25 315 women followed 25 years shows adherence to the Mediterranean diet associated with a 23% reduced all-cause mortality - explained by lipids, inflammation markers and BMI; more than cholesterol or glycemic measures https://t.co/nprDKXMWKp https://t.co/ofoHd8xF8D
The advantage to patient care without the crutch of an EHR. What do you do?
Poster Hall